StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$45.55+1.14 (+2.57%)

Close on Nov 20, 2026Market cap $3.25BP/E –Yield –

Pulse Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Pulse Biosciences's free cash flow for the twelve months ending Jun 30, 2026 was -$61.39M. For fiscal 2025 it was -$54.44M. The highest annual figure on record is -$3.40M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$54.44M–
FY2024Dec 31, 2024-$36.47M–
FY2023Dec 31, 2023-$33.16M–
FY2022Dec 31, 2022-$47.41M–
FY2021Dec 31, 2021-$54.53M–
FY2020Dec 31, 2020-$35.81M–
FY2019Dec 31, 2019-$34.79M–
FY2018Dec 31, 2018-$24.17M–
FY2017Dec 31, 2017-$13.64M–
FY2016Dec 31, 2016-$8.12M–
FY2015Dec 31, 2015-$3.40M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.80M–
Q1 FY2026Mar 31, 2026-$14.63M–
Q4 FY2025Dec 31, 2025-$14.86M–
Q3 FY2025Sep 30, 2025-$13.10M–
Q2 FY2025Jun 30, 2025-$12.91M–
Q1 FY2025Mar 31, 2025-$13.57M–
Q4 FY2024Dec 31, 2024-$9.20M–
Q3 FY2024Sep 30, 2024-$9.06M–
Q2 FY2024Jun 30, 2024-$8.42M–
Q1 FY2024Mar 31, 2024-$9.79M–
Q4 FY2023Dec 31, 2023-$6.83M–
Q3 FY2023Sep 30, 2023-$10.51M–
Q2 FY2023Jun 30, 2023-$9.22M–
Q1 FY2023Mar 31, 2023-$6.61M–
Q4 FY2022Dec 31, 2022-$8.01M–
Q3 FY2022Sep 30, 2022-$10.69M–
Q2 FY2022Jun 30, 2022-$12.84M–
Q1 FY2022Mar 31, 2022-$15.87M–
Q4 FY2021Dec 31, 2021-$12.83M–
Q3 FY2021Sep 30, 2021-$13.51M–
Q2 FY2021Jun 30, 2021-$16.46M–
Q1 FY2021Mar 31, 2021-$11.74M–
Q4 FY2020Dec 31, 2020-$9.53M–
Q3 FY2020Sep 30, 2020-$8.61M–
Q2 FY2020Jun 30, 2020-$7.87M–
Q1 FY2020Mar 31, 2020-$9.79M–
Q4 FY2019Dec 31, 2019-$9.16M–
Q3 FY2019Sep 30, 2019-$8.50M–
Q2 FY2019Jun 30, 2019-$9.76M–
Q1 FY2019Mar 31, 2019-$7.38M–
Q4 FY2018Dec 31, 2018-$6.34M–
Q3 FY2018Sep 30, 2018-$6.92M–
Q2 FY2018Jun 30, 2018-$5.86M–
Q1 FY2018Mar 31, 2018-$5.05M–
Q4 FY2017Dec 31, 2017-$4.11M–
Q3 FY2017Sep 30, 2017-$3.36M–
Q4 FY2016Dec 31, 2016-$2.32M–
Q3 FY2016Sep 30, 2016-$1.99M–

More Pulse Biosciences figures

See a number that looks wrong?